脊髓硬脊膜动静脉瘘手术治疗后抗凝治疗的有效性与长期结局分析
该回顾性研究分析了2006至2016年在本机构治疗的53例脊髓硬脊膜动静脉瘘患者,比较术后治疗性肝素化(A组11例)与常规低剂量肝素血栓预防(B组42例)的效果。B组4例出现急性术后恶化,均经治疗性抗凝后住院期间完全恢复;两组术后恶化发生率无统计学显著差异(P=0.57)。长期随访40例(平均53.4±36个月),两组神经功能状态在入院、出院及末次随访时均无显著差异。
要点
- 术后急性恶化发生率为7.5%(4/53),均经治疗性抗凝后完全恢复。
- A组11例无急性恶化,B组42例中4例出现,组间比较P=0.57,未达统计学显著。
- 长期随访40例(平均53.4±36个月),两组Aminoff-Logue评分在入院、出院及末次随访均无显著差异。
核心结论
- 脊髓硬脊膜动静脉瘘术后急性恶化是临床相关并发症,本组发生率为7.5%。
- 常规治疗性抗凝未显著降低急性恶化率,但术后急性恶化时使用治疗性抗凝可能是安全有效的治疗选择。
研究设计与样本
- 回顾性分析本机构2006至2016年治疗的脊髓硬脊膜动静脉瘘患者医疗数据库。
- 共纳入53例患者,分为A组(术后治疗性肝素化,n=11)和B组(常规低剂量肝素血栓预防,n=42)。
- 采用Aminoff-Logue残疾评分评估入院、出院及末次随访时的神经功能状态。
- 长期分析纳入40例患者,平均随访53.4±36个月。
主要发现
- A组11例无急性术后恶化报告。
- B组42例中4例出现急性术后恶化,均启动治疗性抗凝并在住院期间完全神经功能恢复。
- 术后恶化发生率在治疗组间未达统计学显著差异(P=0.57)。
- 两组神经功能状态在入院时(P=0.093)、出院时(P=0.723)及末次随访时(P=0.222)均无显著差异。
临床怎么用
- 作者认为,术后急性恶化时使用治疗性抗凝可能是安全有效的治疗选择。
局限性
- 本文为回顾性分析。
- 术后恶化发生率组间比较未达统计学显著差异(P=0.57)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Effectiveness and safety of anticoagulation therapy (AC) after treatment of spinal dural arteriovenous fistula (sdAVF) are still inadequately discussed in the literature and are addressed in this study. METHODS: We retrospectively analyzed our medical database for patients with sdAVF treated in our institution between 2006 and 2016. Neurologic status at time of admission, discharge, and last follow-up was assessed via Aminoff-Logue disability score. Patient cohorts were dichotomized as group A (postoperative therapeutic heparinization) and group B (routine thromboembolic prophylaxis with low-dose heparin). RESULTS: Fifty-three patients were included in this analysis. In group A (n = 11), no acute deterioration was reported. In group B (n = 42), 4 patients developed acute postoperative deterioration; therapeutic AC was initiated in all 4 patients resulting in complete neurologic recovery within the inpatient stay. However, the incidence of postoperative deterioration did not reach statistical significance between treatment groups (P = 0.57). Data of 40 patients were available for long-term analysis (mean, 53.4 ± 36 months). Neurologic status did not differ significantly between both groups at time of admission (P = 0.093), discharge (P = 0.723), and last follow-up (P = 0.222). CONCLUSIONS: Acute postoperative deterioration in patients with sdAVF is a clinically relevant complication and was present in 7.5% of patients in our series. Although routine therapeutic AC did not decrease the rate of acute deterioration significantly, our findings imply that therapeutic AC in cases of acute postoperative deterioration might be a safe and efficient treatment option.
引用
- Jablawi F, Schubert GA, Hans FJ, et al. Anticoagulation Therapy After Surgical Treatment of Spinal Dural Arteriovenous Fistula. Effectiveness and Long-Term Outcome Analysis. World Neurosurg. 2018. PMID: 29550595. doi:10.1016/j.wneu.2018.03.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。